Nectar Life Sciences Limited
Indian Pharmaceutical Exporter ยท Advanced Antibiotics Specialist ยท $13.3M Total Trade ยท DGFT Verified
Nectar Life Sciences Limited is an Indian pharmaceutical exporter with a total trade value of $13.3M across 3 products in 1 therapeutic categories. Based on 419 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ceftriaxone ($4.9M), Cefixime ($4.4M), Cefuroxime ($4.0M).
Nectar Life Sciences Limited โ Export Portfolio & Destination Treemap

Who is Nectar Life Sciences Limited? โ Company Overview & Market Position
Nectar Life Sciences Limited, established on June 27, 1995, is a prominent Indian pharmaceutical company specializing in the production and export of finished pharmaceutical formulations, particularly cephalosporins. Headquartered in Chandigarh, India, the company is publicly listed on the Bombay Stock Exchange (BSE) under the ticker symbol 532649 and on the National Stock Exchange of India (NSE) as NECLIFE. As of March 13, 2026, the company's stock was trading at โน11.09 per share. The authorized capital stands at โน35.00 crore, with a paid-up capital of โน22.43 crore. The company employs approximately 1,786 individuals. Nectar Life Sciences Limited's website is neclife.com.